Healthcare Aug 27, 2021 11:45 AM (GMT+8) · EqualOcean
Billion Europe health news on August 27, Guangna Dakang (Guangzhou) Biotechnology Co., Ltd. (hereinafter referred to as Guangna Dakang) recently completed tens of millions of Yuan pre a round of financing, which was exclusively invested by knowledge city (Guangzhou) Investment Group Co., Ltd. (hereinafter referred to as knowledge city group). This round of financing will be mainly used for the construction of Guangna Dakang's production, operation and sales channels, help the industrial transformation of the company's drug detection intelligent POCT products, and promote the development of biosafety rapid detection industry. Established in November 2020, Guangna Dakang focuses on the prevention, control and detection of drug abuse, food safety and animal diseases. Based on the two application platforms of nano marker immunoassay and microfluidic molecular diagnosis, it provides a complete set of rapid detection solutions and leads the technological upgrading in the field of biosafety and mass health rapid detection.

This text is a result of machine translation.